Integrative Insights into Biology, Diagnosis and Treatment of Pulmonary Diseases

Dear Colleagues,

Pulmonary medicine is advancing at an unprecedented pace, driven by breakthroughs in disease biology, innovations in diagnostic technologies, and the development of novel therapeutic strategies. Respiratory disorders—including lung cancer, asthma, COPD, pneumonia, ARDS, interstitial lung diseases, and pleural conditions—remain major contributors to global morbidity and mortality. Understanding their underlying mechanisms and improving diagnostic and treatment approaches are crucial for enhancing patient outcomes.

We are pleased to invite you to contribute to this Special Issue, titled “Integrative Insights into Biology, Diagnosis and Treatment of Pulmonary Diseases”. This collection aims to integrate current knowledge across basic science, translational research, and clinical practice, aligning closely with the scope of Biomedicines, which highlights molecular mechanisms, innovative diagnostics, and therapeutic development.

This Special Issue seeks comprehensive and up-to-date research articles and reviews that address the multifaceted challenges of pulmonary diseases. We welcome submissions exploring biological pathways, emerging diagnostic modalities, biomarker discovery, therapeutic interventions, and translational strategies that bridge bench research with clinical care.

Original research articles and review manuscripts are welcome. Research areas may include, but are not limited to, the following topics:

• asthma
• chronic obstructive pulmonary disease (COPD)
• interstitial lung disease
• lung cancer
• respiratory infection
• obstructive sleep apnea (OSA)
• respiratory failure
• acute respiratory distress syndrome (ARDS)

We look forward to receiving your valuable contributions.

Dr. Te-Chun Shen
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.